GE HealthCare Technologies (GEHC) Scheduled to Post Quarterly Earnings on Tuesday

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) is scheduled to be announcing its earnings results before the market opens on Tuesday, April 30th. Analysts expect the company to announce earnings of $0.90 per share for the quarter. GE HealthCare Technologies has set its FY 2024 guidance at 4.200-4.350 EPS and its FY24 guidance at $4.20-$4.35 EPS.Investors that wish to register for the company's conference call can do so using this link.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.07 by $0.11. The firm had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm's quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.31 earnings per share. On average, analysts expect GE HealthCare Technologies to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.


GE HealthCare Technologies Stock Up 2.3 %

GEHC traded up $1.93 on Tuesday, reaching $86.24. The company's stock had a trading volume of 1,950,627 shares, compared to its average volume of 3,358,135. The stock has a 50 day moving average of $88.84 and a two-hundred day moving average of $78.21. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $39.35 billion, a price-to-earnings ratio of 28.56, a P/E/G ratio of 2.94 and a beta of 0.95. GE HealthCare Technologies has a fifty-two week low of $62.35 and a fifty-two week high of $94.50.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.97%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on GEHC. Argus increased their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a "buy" rating in a report on Monday, April 1st. Evercore ISI increased their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an "outperform" rating in a report on Thursday, April 4th. Morgan Stanley increased their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an "equal weight" rating in a report on Monday, February 12th. Citigroup increased their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a "buy" rating in a report on Wednesday, April 3rd. Finally, HSBC assumed coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They issued a "buy" rating and a $100.00 price objective for the company. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $95.09.

Read Our Latest Analysis on GEHC

GE HealthCare Technologies Company Profile

(Get Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Featured Articles

Earnings History for GE HealthCare Technologies (NASDAQ:GEHC)

Should you invest $1,000 in GE HealthCare Technologies right now?

Before you consider GE HealthCare Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.

While GE HealthCare Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Featured Articles and Offers

Search Headlines: